Atlas Trials

Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT

Clinical trial NCT01523834 · COMPLETED

Trial details

NCT number
NCT01523834
Sponsor
Fondazione Italiana Linfomi - ETS
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2011-02-01
Primary completion
2014-01-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.